首页> 美国卫生研究院文献>Bulletin of the New York Academy of Medicine >Design and Feasibility of a Randomized Behavioral Intervention to Reduce Distributive Injection Risk and Improve Health-Care Access Among hepatitisC virus Positive Injection Drug Users: The Study to Reduce Intravenous Exposures (STRIVE)
【2h】

Design and Feasibility of a Randomized Behavioral Intervention to Reduce Distributive Injection Risk and Improve Health-Care Access Among hepatitisC virus Positive Injection Drug Users: The Study to Reduce Intravenous Exposures (STRIVE)

机译:降低乙型肝炎病毒阳性注射吸毒者中分布式注射风险和改善医疗服务的随机行为干预的设计和可行性:减少静脉暴露的研究(STRIVE)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatitis C virus (HCV) is hyperendemic among injection drug users (IDUs). However, few scientifically proven interventions to prevent secondary transmission of HCV from infected IDUs to others exist. This report describes the design, feasibility, and baseline characteristics of participants enrolled in the Study to Reduce Intravenous Exposure (STRIVE). STRIVE was a multisite, randomized-control trial to test a behavioral intervention developed to reduce distribution of used injection equipment (needles, cookers, cottons, and rinse water) and increase health-care utilization among antibody HCV (anti-HCV) positive IDUs. STRIVE enrolled anti-HCV positive IDU in Baltimore, New York City, and Seattle; participants completed behavioral assessments and venipuncture for HIV, HCV-RNA, and liver function tests (LFTs) and were randomized to attend either a six-session, small-group, peer-mentoring intervention workshop or a time-matched, attention-control condition. Follow-up visits were conducted at 3 and 6 months. At baseline, of the 630 HCV-positive IDUs enrolled (mean age of 26 years, 60% white, 76% male), 55% reported distributive needle sharing, whereas 74, 69, and 69% reported sharing cookers, cottons, and rinse water, respectively. Health-care access was low, with 41% reporting an emergency room as their main source of medical care. Among those enrolled, 66% (418/630) were randomized: 53% (222/418) and 47% (196/418) to the intervention and control conditions, respectively. Follow-up rates were 70 and 73% for the 3- and 6-month visits, respectively. As distributive sharing of used injection equipment was common while reports of receiving HCV care were low, these findings indicate an urgent need for HCV-related interventions with IDUs and demonstrate the acceptability and feasibility to do so.
机译:丙型肝炎病毒(HCV)在注射吸毒者(IDU)中流行。但是,很少有经过科学验证的干预措施能够阻止HCV从受感染的注射毒品使用者向其他人的二次传播。本报告描述了参加减少静脉暴露研究(STRIVE)的参与者的设计,可行性和基线特征。 STRIVE是一项多地点随机对照试验,旨在测试行为干预措施的发展,该行为干预措施旨在减少使用过的注射设备(针头,炊具,棉花和冲洗水)的分布,并提高抗体HCV(抗HCV)阳性IDU之间的医疗利用率。 STRIVE在巴尔的摩,纽约市和西雅图招募了抗HCV阳性IDU;参与者完成了针对HIV,HCV-RNA和肝功能测试(LFT)的行为评估和静脉穿刺,并随机参加了六节,小组,同伴指导的干预研讨会或与时间匹配的注意力控制条件。在3个月和6个月进行随访。基线时,在登记的630例HCV阳性IDU中(平均年龄26岁,白人占60%,男性占76%),其中55%的人报告了共用的针头分配,而74、69和69%的人则报告了共用炊具,棉花和冲洗剂水分别。卫生保健的普及率很低,有41%的人报告急诊室是他们的主要医疗来源。在参与研究的患者中,有66%(418/630)是随机分组的:干预和对照条件分别为53%(222/418)和47%(196/418)。 3个月和6个月的随访率分别为70%和73%。由于二手注射设备的分配共享很普遍,而接受HCV护理的报告很少,这些发现表明迫切需要对IDU进行HCV相关干预,并证明这样做的可接受性和可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号